Health News
Graveyard Shift Associated With Teen MS Risk
The overnight shift might seem like an easy way to make money, but a new study warns that disrupting your sleep cycle as a teen can increase your risk of developing multiple sclerosis.
Fast Attack on MS
The sooner you treat a disease like multiple sclerosis (MS), the better the outcome, right? Well, that statement appears to be somewhat true.
MS: A Mysterious Malady
Multiple sclerosis (MS) is a puzzling disease. While scientists know little about the causes of MS, they know much more about its potentially debilitating effects.
The Molecule of Many Diseases
It is good news when researchers gain a little more knowledge about the development of one disease. It is even better news when that little bit of knowledge applies to a whole group of diseases.
New Dietary MS Therapy
The dietary supplement glucosamine is popular for helping aching, arthritic joints. A new supplement looks like it could suppress the damaging autoimmune response seen in multiple sclerosis (MS).
New MS Drug on the Horizon
People with multiple sclerosis (MS) experience their symptoms in episodes. To curb these episodes, there are a few medications patients can take. Now, there may be a new drug option for people with MS.
The Jury is Still out
Studies have shown a possible connection between blocked veins and multiple sclerosis (MS). But these studies may have been designed poorly, leaving this topic in need of more research.
FDA approves Botox to treat specific form of urinary incontinence
The U.S. Food and Drug Administration today approved Botox ( onabotulinumtoxinA ) injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.
FDA Drug Safety Communication: Tysabri
The U.S. Food and Drug Administration (FDA) continues to evaluate the risk of progressive multifocal leukoencephalopathy ( PML ), a rare but serious brain infection, associated with use of Tysabri ( natalizumab ) for the treatment of multiple sclerosis (MS) and Crohn's disease.
The Cost of MS
There is no denying that healthcare in the U.S. has become expensive. For some multiple sclerosis (MS) patients, the cost of new drugs may not be worth the price.